Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00392236
What this trial is testing

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

Who this might be right for
Schizophrenia
Northwell Health 55
Not applicableStudy completedNCT03049800
What this trial is testing

Is Cognitive Training Neuroprotective in Early Psychosis?

Who this might be right for
PsychosisHealthy
University of Minnesota 36
Not applicableUnknownNCT00717509
What this trial is testing

Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia

Who this might be right for
SchizophreniaMetabolic SyndromeGenetic Polymorphism
Seoul National Hospital 150
Not applicableEnrolling By InvitationNCT06792175
What this trial is testing

Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models

Who this might be right for
Autism Spectrum DisorderDepression - Major Depressive DisorderAnxiety, Generalized+5 more
Psyrin Inc. 500
Not applicableStudy completedNCT04218981
What this trial is testing

Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

Who this might be right for
Common Mental Disorder
Central South University 200
Post-approval studies (Phase 4)Study completedNCT00090012
What this trial is testing

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Eli Lilly and Company 340
Not applicableLooking for participantsNCT01730781
What this trial is testing

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Who this might be right for
SchizophreniaCannabis DependenceProdromal for Psychotic Illness+4 more
Yale University 100
Not applicableStudy completedNCT01376492
What this trial is testing

FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 709
Testing effectiveness (Phase 2)Ended earlyNCT01832766
What this trial is testing

The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes

Who this might be right for
Schizophrenia
University of Colorado, Denver 13
Not applicableStudy completedNCT01641900
What this trial is testing

Effects of Eszopiclone on Sleep and Memory in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 59
Not applicableStudy completedNCT01768000
What this trial is testing

The Family Cognitive Adaptation Training Manual: A Test of Effectiveness

Who this might be right for
Psychosis
Centre for Addiction and Mental Health 40
Post-approval studies (Phase 4)Study completedNCT00492336
What this trial is testing

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 84
Not applicableUnknownNCT02842034
What this trial is testing

Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 60
Post-approval studies (Phase 4)Study completedNCT00711464
What this trial is testing

Modafinil Effects on Cognition in Schizophrenia Patients

Who this might be right for
Schizophrenia
University of California, Los Angeles 29
Post-approval studies (Phase 4)Study completedNCT00436371
What this trial is testing

Amisulpride in Schizophrenic Acute Phase Patients

Who this might be right for
Schizophrenia
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT00000371
What this trial is testing

Trial of D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 60
Not applicableStudy completedNCT01031563
What this trial is testing

Risk Perception in Drug-Dependent Adults With and Without Schizophrenia

Who this might be right for
Cocaine DependenceCannabis DependenceSchizophrenia
National Institute on Drug Abuse (NIDA) 120
Not applicableLooking for participantsNCT05731414
What this trial is testing

Outcomes From Remediation and Behavioural Intervention Techniques

Who this might be right for
SchizophreniaPsychosisPsychotic Disorders+1 more
University of Toronto 360
Not applicableStudy completedNCT00572247
What this trial is testing

The Psychiatric Rehabilitation Approach to Weight Loss

Who this might be right for
Schizophrenic Disorders
University of Kansas 133
Not applicableEnded earlyNCT06002958
What this trial is testing

Horyzons: Implementation and Integration in Clinical Practice

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University of North Carolina, Chapel Hill 52
Next Page